Browsing by Author "Obrenovic, B. (6506095227)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Clinical and functional evaluation of the Carbomedics Prosthetic Heart Valve in the mitral position. Preliminary results(1990) ;Subotic, S. (57163547100) ;Petrovic, P. (57198305352) ;Boskovic, D. (59808752300) ;Obrenovic, B. (6506095227) ;Sindjelic, R. (6602803313) ;Lovric, Z. (55441063100) ;Djukic, P. (6508205447) ;Vranes, M. (6701667966) ;Curcic, S. (6701473338)Matic, A. (7003674642)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Life-threatening bleeding due to an acquired inhibitor to factor XII-XI successfully treated with 'activated' prothrombin complex concentrate (FEIBA)(1982) ;Rolovic, Z. (7006321033) ;Elezovic, I. (12782840600) ;Obrenovic, B. (6506095227)Rizza, C. (58439940000)Five instances of inhibitor to factor XII-XI have been reported so far. These have arisen in two women suffering from systemic lupus erythematosus and in three patients with Waldenstrom macroglobulinaemia. None of these patients had a bleeding tendency. The authors believe that it is of interest to report a 45-year-old female with an 18 years history of a bleeding tendency, who developed life-threatening vaginal bleeding following total hysterectomy for rupture of an ovarian cyst. Coagulation studies revealed a prolonged whole blood clotting time of 19 min and an activated partial thromboplastin time of 199 s (control 40 s). Further experiments showed that the patient's plasma at the dilution of 1:32 inhibited a contact product preparation thus indicating an inhibitor to factor XII-XI. The patient was treated with a variety of blood products without success but the administration of FEIBA 60 units/kg/d for 4 d was followed by the arrest of bleeding. The patient recovered completely. She had no evidence of an associated systemic disease but the inhibitor is still present in the plasma.